Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05884697 · ClinicalTrials.gov registry record · NA
Let's K-Talk - HPV Study for Ethnic Koreans
A NA study of Papillomavirus Vaccines and Human Papillomavirus Viruses, sponsored by University of Cincinnati.
- Active
- Registry status
- NA
- Development phase
- 120
- Enrollment target
- 1
- Study location
NCT05884697 is a NA study of Papillomavirus Vaccines and Human Papillomavirus Viruses that is active but no longer recruiting, run by University of Cincinnati. The registered enrollment target is 120 participants, below the 3,882-participant average among 4 other Papillomavirus Vaccines trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state.
The verdict
NCT05884697, a NA study of Papillomavirus Vaccines and Human Papillomavirus Viruses, is active but no longer recruiting, sponsored by University of Cincinnati.
- ACTIVE NOT RECRUITING
- Registry status
- NA
- Development phase
- 120 participants
- Enrollment target
- 1
- Study location
Study Summary
The goal of this clinical trial is to test the feasibility, acceptability, and preliminary efficacy of a storytelling video-based intervention using AI chatbot technology (K-Talk) to promote HPV vaccination behavior among Korean Americans aged 18 to 45. The main questions this study aims to answer are: * Is the K-Talk intervention feasible for use among Korean Americans aged 18 to 45? * Is the K-Talk intervention acceptable to the target population? * What is the preliminary efficacy of the K-Talk intervention in promoting HPV vaccination uptake? Participants will be Korean Americans aged 18 to 45 who are at risk for HPV infection. Participants will be asked to complete a baseline survey and then will be "randomized" into one of four groups: Group 1 (chatbot + storytelling intervention), Group 2 (chatbot only), Group 3 (storytelling only), and Group 4 will be only exposed to written didactic HPV education materials. All groups will receive written didactic HPV education materials. Researchers will compare how Group 1, a combination of AI Chatbot and storytelling intervention is more effective than other intervention groups in promoting HPV vaccination uptake among underserved, hard-to-reach Korean Americans.
Conditions Studied
Interventions
- OTHER K-Talk Intervention (Storytelling and K-Bot)
- OTHER Storytelling Intervention
- OTHER K-Bot Intervention
- OTHER Written Information
Study Locations (1)
Ohio
- Minjin Kim - Cincinnati
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 120 participants |
| Start Date | 2023-05-10 |
| Est. Completion | 2026-07-31 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05884697
The ClinicalTrials.gov registry entry for NCT05884697 describes a study currently listed as active not recruiting, categorized as NA. The registered enrollment target is 120 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 3,882-participant average among 4 other Papillomavirus Vaccines trials with a reported enrollment target (97% lower). The listed sponsor is University of Cincinnati, which has 245 total studies on file at ClinicalTrials.gov.
The record links to 2 conditions, with Papillomavirus Vaccines appearing as the primary indexed condition, and to 4 interventions - of which K-Talk Intervention (Storytelling and K-Bot) is the first listed.
NCT05884697 reports 1 study location spanning 1 distinct geographic area - top geographies include Ohio.
Frequently Asked Questions
What is clinical trial NCT05884697 about?
NCT05884697 is a clinical study titled "Let's K-Talk - HPV Study for Ethnic Koreans". The goal of this clinical trial is to test the feasibility, acceptability, and preliminary efficacy of a storytelling video-based intervention using AI chatbot technology (K-Talk) to promote HPV vaccination behavior among Korean Americans aged 18 to 45. The main questions this study aims to answer ...
What is the current status of trial NCT05884697?
This trial is currently active not recruiting. It is a NA study. The enrollment target is 120 participants. The study started on 2023-05-10. Estimated completion is 2026-07-31.
What conditions does trial NCT05884697 study?
This clinical trial studies the following conditions: Papillomavirus Vaccines, Human Papillomavirus Viruses.
What interventions are being tested in trial NCT05884697?
The interventions under investigation include: K-Talk Intervention (Storytelling and K-Bot) (OTHER), Storytelling Intervention (OTHER), K-Bot Intervention (OTHER), Written Information (OTHER).
Who is sponsoring clinical trial NCT05884697?
This trial is sponsored by University of Cincinnati, which has 245 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT05884697 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Papillomavirus Vaccines
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
ReMARK: Addressing Disparities in Rural HPV-related Cancer Prevention
RECRUITING · NA
-
Impact of Adolescent Vaccine Reminder Notices Sent Via Preferred Method of Communication on HPV Vaccination
ACTIVE NOT RECRUITING · NA
-
Provider-Focused Intervention for Maximizing HPV Vaccine Uptake in Young Cancer Survivors
ACTIVE NOT RECRUITING · NA
-
Immunogenicity of Gardasil-9 HPV Vaccine in People Living With HIV
RECRUITING · Phase 4
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.